Startup | December 05, 2021
Apollo Health Ventures closes US $ 180 million fund
The fund aims at investing in companies that extends human healthspan
The fund aims at investing in companies that extends human healthspan
Focused medicines company delivering strong operational performance. Building depth in five core therapeutic areas, strength in technology platforms, and a balanced geographic footprint
In 2019, diabetes was the ninth leading cause of death with an estimated 1.5 million deaths directly caused by diabetes, as per WHO
Oravax's vaccine technology is highly scalable for manufacturing and is easily transferable for wide scale logistical distribution, as there is no need for freezer storage
Transaction adds to Sanofi pipeline a potential first-in-class vaccine candidate in acne vulgaris, a condition affecting millions of people worldwide
She replaces Victoria Tabiner, who is stepping down after 10 years at Sygnature
According to a survey conducted by FOGSI last year, 92% of the doctors opined that anaemia due to iron deficiency can be eradicated in five years
Sciflix is a special Initiative by Lupin to assist future pulmonologists in staying abreast of the latest medical advances relevant to their speciality
ALASTIN’s patented, differentiated technology and products are highly synergistic with Galderma’s premium portfolio
The Omicron variant doesn't escape RTPCR and RAT; States advised to ramp up testing for prompt and early identification of any cases
Subscribe To Our Newsletter & Stay Updated
